Search Magazine Archives

Sort by:

Resurrecting Therapy

Putting Big Pharma on the Couch

September/October 2019
In 1986, people being treated for depression were twice as likely to be in therapy as to be taking pills. Now, for every person in therapy, there are four times as many taking pills for depression. Isn’t it time we stage our comeback?
Bonus - Read the entire article FREE!

A Bridge to Recovery

A Grassroots Approach to the Opioid Crisis

September/October 2019
Years into the opioid epidemic, a journalist travels to the hardest-hit state to get an up-close look at addiction treatment and the “radically demedicalized” approach one clinic says can make all the difference.

Fighting the Epidemic

An Interview with the Author of Dopesick

September/October 2019
An interview with Beth Macy, author of Dopesick, on solution-oriented journalism and creative ways of confronting the opioid crisis.
Bonus - Read the entire article FREE!

Clinician's Digest

Is Ketamine the New Antidepressant to Rave About?

May/June 2015
Is a new generation of antidepressants on the way?

The State of Our Art

Do Our Old Ways Fit the New Times?

March/April 2015
While the number of people in psychotherapy keeps declining, surveys reveal that potential clients would still rather talk to a therapist than fill a prescription. So what’s going on? We asked six of the field’s most outspoken leaders to offer their views.
Bonus - Read the entire article FREE!

Falling in Love Again

A Brief History of Psychoactive Drugs

July/August 2014
Over the last 150 years, we’ve seen waves of mass infatuations with psychotropic drugs—antidepressants being the latest. While all these drugs are different, their story arc seems to follow a predictable course.
Bonus - Read the entire article FREE!

The Meds of the Future

Waiting for the Next Magic Pill

July/August 2014
Does our growing understanding of the brain and the prospect of further scientific discoveries mean there’s a new generation of magical pills on the horizon?

SSRIs in Perspective

Have They Lived up to Their Promise?

July/August 2014
After wading through the controversies and contradictions in the research literature on SSRIs, a critic of Big Pharma explains why he thinks these drugs may have gotten a bad rap.

The Book We Love to Hate

Why DSM-5 Makes Nobody Happy

March/April 2014
From small insignificant beginnings in 1952, when almost nobody read it, DSM has become a kind of sacred literary monster. Today, it’s the most detested and certainly the most debated mental health classification scheme ever devised.
Bonus - Read the entire article FREE!

Shedding Light on DSM-5

The View from the Trenches

March/April 2014
While the polemical debates over the new DSM have received widespread coverage, the reactions of ordinary clinicians have yet to receive much scrutiny.
Page 1 of 3 (23 Magazine Articles)